Working… Menu
Trial record 3 of 4 for:    MS1819

Phase 2 Combination Study With Escalating Doses of MS1819-SD on Top of a Stable Dose of PPEs

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04302662
Recruitment Status : Completed
First Posted : March 10, 2020
Last Update Posted : August 19, 2021
Information provided by (Responsible Party):
AzurRx SAS

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 3, 2021
Actual Study Completion Date : June 3, 2021